Greg L Beilhartz - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Greg L Beilhartz

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Cell|June 27, 2020

Recognition of Semaphorin Proteins by P. sordellii Lethal Toxin Reveals Principles of Receptor Specificity in Clostridial ToxinsHunsang Lee, Greg L Beilhartz, Iga Kucharska, et al.

Antiviral Therapy|October 26, 2011

Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humansNoortje M van Maarseveen, Annemarie Mj Wensing, Dorien de Jong, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020

bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)Shuhui Lim, Regina Khoo, Khong Ming Peh, et al.

The Journal of Biological Chemistry|October 31, 2014

Derivatives of mesoxalic acid block translocation of HIV-1 reverse transcriptaseJean A Bernatchez, Rakesh Paul, Egor P Tchesnokov, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025

De novo design of potent inhibitors of clostridial family toxinsRobert J Ragotte, Huazhu Liang, John Tam, et al.

Nature Cancer|September 11, 2023

A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastomaWeifan Dong, Adam Fekete, Xiaodi Chen, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Cell|June 27, 2020

Recognition of Semaphorin Proteins by P. sordellii Lethal Toxin Reveals Principles of Receptor Specificity in Clostridial ToxinsHunsang Lee, Greg L Beilhartz, Iga Kucharska, et al.

Antiviral Therapy|October 26, 2011

Telbivudine exerts no antiviral activity against HIV-1 in vitro and in humansNoortje M van Maarseveen, Annemarie Mj Wensing, Dorien de Jong, et al.

Proceedings of the National Academy of Sciences of the United States of America|March 4, 2020

bioPROTACs as versatile modulators of intracellular therapeutic targets including proliferating cell nuclear antigen (PCNA)Shuhui Lim, Regina Khoo, Khong Ming Peh, et al.

The Journal of Biological Chemistry|October 31, 2014

Derivatives of mesoxalic acid block translocation of HIV-1 reverse transcriptaseJean A Bernatchez, Rakesh Paul, Egor P Tchesnokov, et al.

Proceedings of the National Academy of Sciences of the United States of America|September 22, 2025

De novo design of potent inhibitors of clostridial family toxinsRobert J Ragotte, Huazhu Liang, John Tam, et al.

Nature Cancer|September 11, 2023

A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastomaWeifan Dong, Adam Fekete, Xiaodi Chen, et al.

Pageof 3